These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2947249)

  • 1. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K; Rivet JM; Millan MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of spinal cord 5-HT1A and 5-HT1B receptors in the modulation of a spinal nociceptive reflex.
    Eide PK; Joly NM; Hole K
    Brain Res; 1990 Dec; 536(1-2):195-200. PubMed ID: 2150769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
    Millan MJ; Bervoets K; Colpaert FC
    Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
    Millan MJ; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness.
    Eide PK; Hole K
    Neuropharmacology; 1991 Jul; 30(7):727-31. PubMed ID: 1717872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.
    Carli M; Tranchina S; Samanin R
    Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
    Bendotti C; Samanin R
    Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.